UNSPSC 51472301: Camphora

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DLC36A01X. European Medicines Agency schedules Camphora in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13214MIG. Camphora generally arises in the molecular formula C6H5CLO. The term 'camphora' is an International Nomenclature of Cosmetic Ingredients designation. SMILES: C1=CC(=CC=C1O)CL. SMILES: C1=CC(=CC=C1O)CL.

UNSPSC 51472301 Camphora, a Commodity code, represents products state and local governments procure as components within broader janitorial, operational, and pharmaceutical supply contracts. Recent solicitations show camphora appearing within larger consumable-goods acquisitions rather than as a standalone line item; the code applies to camphora as an active ingredient or component in over-the-counter products, topicals, and industrial supplies rather than as a raw material purchase. State and local buyers sourcing under this code include county boards and cooperative purchasing alliances. The Hillsborough County Board of County Commissioners in Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represent the recent buyer base for products falling within this commodity classification.

Geographic activity concentrates in Florida and Minnesota, with MMCAP extending reach to Oregon and other participating state and local entities. The Hillsborough County Board of County Commissioners issued an ITB for Janitorial and Operational Supplies due July 24, 2026, with an estimated contract value of $765,679.84 for one year, serving the Hillsborough County Fire Rescue Department across 47 fire stations; delivery is required within 10 days of purchase order receipt to the Public Safety Operations Complex in Tampa, Florida. MMCAP issued an RFP due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities, with awarded vendors effective July 1, 2026, requiring compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. Both opportunities require new, unused products in original packaging and authorized distributor status for all items bid.